Order of the President of the General Court of 22 June 2018 — Arysta LifeScience Netherlands v Commission

(Case T-476/17 R)

((Application for interim measures - Plant protection products - Active substance diflubenzuron - Conditions of approval for placing on the market - Application for suspension of operation - Lack of urgency - Balancing of interests))

(2018/C 301/44)

Language of the case: English

Parties

Applicants: Arysta LifeScience Netherlands BV (Amsterdam, Netherlands) (represented by C. Mereu and M. Grunchard, lawyers)

Defendant: European Commission (represented by: A. Lewis, I. Naglis and G. Koleva, acting as Agents)

Re:

Application based on Articles 278 and 279 TFEU, seeking suspension of the operation of Commission Implementing Regulation (EU) 2017/855 of 18 May 2017 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance diflubenzuron (OJ 2017 L 128, p. 10)

Operative part of the order

1.	The application for interim measures is dismissed.

2.	The costs are reserved.